Free Trial
LON:OCTP

Oxford Cannabinoid Technologies (OCTP) Share Price, News & Analysis

Oxford Cannabinoid Technologies logo
GBX 0.12
-0.01 (-4.17%)
(As of 06/5/2024)

About Oxford Cannabinoid Technologies Stock (LON:OCTP)

Key Stats

Today's Range
0.12
0.20
50-Day Range
0.12
0.12
52-Week Range
0.05
1.38
Volume
11.40 million shs
Average Volume
9.33 million shs
Market Capitalization
£1.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.

Receive OCTP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Cannabinoid Technologies and its competitors with MarketBeat's FREE daily newsletter.

OCTP Stock News Headlines

Oxford Cann Share Chat
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
See More Headlines

OCTP Stock Analysis - Frequently Asked Questions

Oxford Cannabinoid Technologies' stock was trading at GBX 0.63 at the start of the year. Since then, OCTP shares have decreased by 81.6% and is now trading at GBX 0.12.
View the best growth stocks for 2024 here
.

Shares of OCTP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Cannabinoid Technologies investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Brookfield Business Partners (BBU.UN), Bearing Lithium (BRZ), (BSFT) (BSFT), BTCS (BTCS) and BTC Digital (BTCTW).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
£-4,240,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Outstanding Shares
1,090,000,000
Free Float
N/A
Market Cap
£1.25 million
Optionable
Not Optionable
Beta
0.82
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (LON:OCTP) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners